Multiple Sclerosis
Conference Coverage
Ocrelizumab’s Benefits on Confirmed Disability Improvement Persist in Open-Label Extension
NASHVILLE—The benefits of ocrelizumab on 24-week confirmed disability improvement, which were demonstrated in two-year, double-...
Video
Global MS trends: A chaotic picture with risk as the central theme
It’s tough to draw firm conclusions from the vastly varied studies assessing epidemiologic patterns of MS around the world, says Dr. Alberto...
Video
Focus on preventing comorbidities in MS, physician urges
NASHVILLE, TENN. – It’s a kind of ‘lifestyle disease’ since other conditions can worsen it, Dr. Allen C. Bowling says, so healthier living is...
Video
Pregnancy may be ideal time to consider switching MS drugs
NASHVILLE, TENN – Women with multiple sclerosis who fare poorly on specific medications before pregnancy don’t tend to do any better afterward, a...
Video
MS clinic thrives by making regular care a ‘loss leader’
To make make up for losses, the Atlanta center has begun offering its own ancillary services.
Video
New guidelines for gadolinium-based contrast agents take conservative stance
NASHVILLE, TENN. – The agents remain necessary in initial diagnosis and other specific clinical scenarios.
Video
VIDEO: PML prevention is possible, even when treating patients with aggressive MS
NASHVILLE, TENN. – Short treatment periods with natalizumab are possible for patients with aggressive disease, even with JC virus antibody...
Conference Coverage
Can Neurologists Predict a Patient’s Nonadherence to DMTs for MS?
NASHVILLE—Demographic characteristics, comorbidities, and previous treatments can predict intentional and unintentional...
Conference Coverage
How Does the Gut Microbiome Differ in Patients With Relapsing MS Versus Controls?
NASHVILLE—The microbiome composition of patients with multiple sclerosis (MS) may differ significantly from that of healthy...
Conference Coverage
A Mediterranean Diet May Be Associated With Lower Depression and Cognitive Impairment Scores in Patients With MS
Conference Coverage
Oligoclonal Bands May Predict MS Relapses and Progression
NASHVILLE—Patients with multiple sclerosis (MS) and 10 or more oligoclonal bands (OCBs) in CSF may have significantly more...